Home  »  Business   »  GreenLight Biosciences Holdings’s (NASDAQ: GRNA)...

GreenLight Biosciences Holdings’s (NASDAQ: GRNA) Stock Price Will Be Bearish Or Bullish In 2022

GreenLight Biosciences Holdings (NASDAQ:GRNA) shares, rose in value on Thursday, 08/04/22, with the stock price up by 27.61% to the previous day’s close as strong demand from buyers drove the stock to $4.16.

Actively observing the price movement in the last trading, the stock closed the session at $3.26, falling within a range of $4.0106 and $5.8999. Referring to stock’s 52-week performance, its high was $15.80, and the low was $1.91. On the whole, GRNA has fluctuated by 108.00% over the past month.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that GRNA’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium term indicators have put the stock in the category of 50% Sell while long term indicators on average have been pointing out that it is a 100% Sell.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of GRNA currently trading nearly 85.12% and 10.69% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 71.49, while the 7-day volatility ratio is showing 24.02% which for the 30-day chart, stands at 14.75%. Furthermore, GreenLight Biosciences Holdings (GRNA)’s average true range (ATR) is 0.50.

Data on historical trading for GreenLight Biosciences Holdings (NASDAQ:GRNA) indicates that the trading volumes over the past 10 days have averaged 0.27 million and over the past 3 months, they’ve averaged 293.18K. According to company’s latest data on outstanding shares, there are 113.56 million shares outstanding.

Nearly 1.10% of GreenLight Biosciences Holdings’s shares belong to company insiders and institutional investors own 24.90% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.68 million shares as on Jul 14, 2022, resulting in a short ratio of 4.79. According to the data, the short interest in GreenLight Biosciences Holdings (GRNA) stood at 1.36% of shares outstanding as of Jul 14, 2022; the number of short shares registered in Jun 14, 2022 reached 2.0 million. The stock has fallen by -58.06% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the GRNA stock heading into the next quarter.

Leave a Comment

Your email address will not be published.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]